InvestorsHub Logo

Hugon

04/29/21 9:19 AM

#357409 RE: sunspotter #357389

This post is 'spot on'. Great analysis. If big pharma thought IPIX had a winner, surely Brilacidin would be long gone from being available, and surely IPIX would have completed a deal adequate to shareholders. Instead, the world waits for 1) Their results 2) perhaps more importantly knowing IPIX's post trial track record: can they do anything of great significance with their post trial results (provided not a failed trial), or will it languish for years and years to come and move on to another new or old asset.

falcon74

04/30/21 9:21 AM

#357535 RE: sunspotter #357389

The ONLY thing that most longs will agree with you on is that...

NO ONE KNOWS WHAT THE RESULTS ON THE CLINICAL TRIAL ARE NOW AND WILL NOT KNOW UNTIL THE DOUBLE BLIND TRIAL IS COMPLETED AND THE CRO DOES THEIR ANNAYSIS OF THE TRIAL RESULTS WHICH WILL THEN BE RELEASED BY IPIX.....PERIOD!!

To state or insinuate that because we have heard nothing from other pharmas means they are not interested in Brilacidin....is pure speculation......that is unless you or someone you know has insider information.

It has been a long road and longs will wait until the trial is completed.

falcon74

04/30/21 11:38 AM

#357561 RE: sunspotter #357389

Sunny & Dud....

NO ONE KNOWS WHAT THE RESULTS ON THE CLINICAL TRIAL ARE NOW AND WILL NOT KNOW UNTIL THE DOUBLE BLIND TRIAL IS COMPLETED AND THE CRO DOES THEIR ANNAYSIS OF THE TRIAL RESULTS WHICH WILL THEN BE RELEASED BY IPIX.....PERIOD!!

To state or insinuate that because we have heard nothing from other pharmas means they are not interested in Brilacidin....is pure speculation......that is unless you or someone you know has insider information.

It has been a long road and longs will wait until the trial is completed.